pharmjournalРазработка и регистрация лекарственных средствDrug development & registration2305-20662658-5049LLC «CPHA»10.33380/2305-2066-2020-9-3-36-43pharmjournal-827Research ArticleФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯPHARMACEUTICAL TECHNOLOGYИнтерполимерные комплексы на основе Eudragit® EPO/Eudragit® S100 как перспективные носители для пероральных систем контролируемой доставкиInterpolymer Complexes Based on Eudragit® EPO/Eudragit® S100 as Carriers for Oral Controlled Drug Delivery Systemshttps://orcid.org/0000-0001-8179-4516Ситенкова (Буховец)А. В.BukhovetsA. V.

Ситенкова (Буховец) Александра Викторовна – доцент.

420126, Республика Татарстан, Казань, ул. Фатыха Амирхана, д. 16.

Aleksandra V. Bukhovets.

16, Fatykha Amirkhan str., Kazan, Republic of Tatarstan, 420126.

a.bukhovets@gmail.comhttps://orcid.org/0000-0002-0192-4585СитенковА. Ю.SitenkovA. Y.

Ситенков Александр Юрьевич – ассистент.

420126, Республика Татарстан, Казань, ул. Фатыха Амирхана, д. 16.

Alexander Y. Sitenkov.

16, Fatykha Amirkhan str., Kazan, Republic of Tatarstan, 420126.

alex.sit2010@yandex.ruhttps://orcid.org/0000-0002-0916-2853МустафинР. И.MoustafineR. I.

Мустафин Руслан Ибрагимович – директор.

420126, Республика Татарстан, Казань, ул. Фатыха Амирхана, д. 16.

Rouslan I. Moustafine.

16, Fatykha Amirkhan str., Kazan, Republic of Tatarstan, 420126.

rouslan.moustafine@gmail.comИнститут фармации ФГБОУ ВО Казанский ГМУ Минздрава РоссииInstitute of Pharmacy, Kazan State Medical University202020082020933643Copyright &#x00A9; Ситенкова (Буховец) А.В., Ситенков А.Ю., Мустафин Р.И., 20202020Ситенкова (Буховец) А.В., Ситенков А.Ю., Мустафин Р.И.Bukhovets A.V., Sitenkov A.Y., Moustafine R.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pharmjournal.ru/jour/article/view/827интерполимерные комплексыEudragit®диклофенак натриятеофиллинпероральная доставкаконтролируемая доставка активных фармацевтических ингредиентовinterpolymer complexesEudragit®diclofenac sodiumtheophyllineoral deliverycontrolled drug deliveryИсследование выполнено при финансовой поддержке Российского научного фонда (научный проект № 20-65-46007). Авторы выражают благодарность компании ERWEKA GmbH за предоставленную возможность выполнения работы на приборе DFZ II «Проточная ячейка», а также компании Evonik Rohm GmbH за предоставление образцов сополимеров Eudragit<sup>®</sup>.This work was financially supported by the Russian Science Foundation (RSF) in the framework of research project № 20-65-46007 (to A.V.B. and R.I.M.). The authors are also grateful to ERWEKA GmbH for the opportunity to work on the Flow Trough Cell Apparatus DFZ II, and also to Evonik Rohm GmbH for providing samples of Eudragit<sup>®</sup> copolymers.ReferencesPatra Ch. N., Priya R., Swain S., Jena G. K., Panigrahi K. C., Ghose D. Pharmaceutical significance of Eudragit: A review. Future Journal of Pharmaceutical Sciences. 2017;3(1):33-45. Doi: 10.1016/j.fjps.2017.02.001.Patra Ch. N., Priya R., Swain S., Jena G. K., Panigrahi K. C., Ghose D. Pharmaceutical significance of Eudragit: A review. Future Journal of Pharmaceutical Sciences. 2017;3(1):33-45. Doi: 10.1016/j.fjps.2017.02.001 .Gallardo D., Skalsky B., Kleinebudde P. Controlled release solid dosage forms using combinations of (meth)acrylate copolymer. Pharmaceutical Development Technology. 2008;13:413-423. Doi: 10.1080/10837450802202098.Gallardo D., Skalsky B., Kleinebudde P. Controlled release solid dosage forms using combinations of (meth)acrylate copolymer. Pharmaceutical Development Technology. 2008;13:413-423. Doi: 10.1080/10837450802202098.Мустафин Р. И. Интерполимерные сочетания химически комплементарных типов сополимеров Eudragit® как новое направление в создании пероральных систем доставки и лекарственных форм с модифицированным высвобождением. Химико-фармацевтический журнал. 2011;45(5):28-39. Doi: 10.30906/0023-1134-2011-45-5-28-39.Mustafin R. I. Interpolymer combinations of chemically complementary grades of Eudragit® copolymers: A new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release. Himiko-farmacevticheskij zhurnal = Pharmaceutical Chemistry Journal. 2011;45:285-295. Doi: 10.1007/s11094-011-0618-7. (In Russ.).Moustafine R. I., Bobyleva V. L., Bukhovets A. V., Garipova V. R., Kabanova T. V., Kemenova V.A ., Van den Mooter G. Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit® EPO/Eudragit® L100-55). Journal of Pharmaceutical Sciences. 2011;100:874-885. Doi: 10.1002/jps.22320.Moustafine R. I., Bobyleva V. L., Bukhovets A. V., Garipova V. R., Kabanova T. V., Kemenova V.A ., Van den Mooter G. Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit® EPO/Eudragit® L100-55). Journal of Pharmaceutical Sciences. 2011;100:874-885. Doi: 10.1002/jps.22320.Moustafine R. I., Bukhovets A. V., Sitenkov A. Y., Kemenova V. A., Rombaut P., Van den Mooter G. Eudragit® EPO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged Eudragit® L100 copolymers. Molecular Pharmaceutics. 2013;10(7):2630-2641. Doi: 10.1021/mp4000635.Moustafine R. I., Bukhovets A. V., Sitenkov A. Y., Kemenova V. A., Rombaut P., Van den Mooter G. Eudragit® EPO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged Eudragit® L100 copolymers. Molecular Pharmaceutics. 2013;10(7):2630-2641. Doi: 10.1021/mp4000635.Mustafin R. I., Bukhovets A. V., Sitenkov A. Yu., Garipova V. R, Kemenova V. A., Rombaut P., Van den Mooter G. Synthesis and characterization of a new carrier based on Eudragit® EPO/S100 interpolyelectrolyte complex for controlled colon-specific drug delivery. Pharmaceutical Chemistry Journal. 2011;45:568-574. Doi: 10.1007/s11094-011-0681-0.Mustafin R. I., Bukhovets A. V., Sitenkov A. Yu., Garipova V. R, Kemenova V. A., Rombaut P., Van den Mooter G. Synthesis and characterization of a new carrier based on Eudragit® EPO/S100 interpolyelectrolyte complex for controlled colon-specific drug delivery. Pharmaceutical Chemistry Journal. 2011;45:568-574. Doi: 10.1007/s11094-011-0681-0.Мустафин Р. И., Кабанова Т. В., Семина И. И., Буховец А. В., Гарипова В. Р., Шиловская Е. В., Насибуллин Ш. Ф., Ситенков А. В., Казакова Р. Р., Кеменова В.А. Биофармацевтическая оценка поликомплексной матричной системы доставки в толстый отдел кишечника на основе Carbomer 940/Eudragit® EPO. Химико-фармацевтический журнал. 2011;45(8):41-44. Doi: 10.30906/0023-1134-2011-45-8-41-44.Mustafin R. I., Kabanova T. V., Semina I. I., Bukhovets A. V., Garipova V. R., Shilovskaya E. V., Nasibullin S. F., Sitenkov A. Y., Kazakova R. R., Kemenova V. A. Biopharmaceutical assessment of polycomplex matrix system based on Carbomer 940 and Eudragit® EPO for colon-specific drug delivery. Himiko-farmacevticheskij zhurnal = Pharmaceutical Chemistry Journal. 2011;45(8):41-44. Doi: 10.30906/0023-1134-2011-45-8-41-44. (In Russ.).Moustafine R. I., Salachova A. R., Frolova E. S., Kemenova V. A., Van den Mooter G. Interpolyelectrolyte complexes of Eudragit® EPO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Development and Industrial Pharmacy. 2009;35:1439-1451. Doi: 10.3109/03639040902988574.Moustafine R. I., Salachova A. R., Frolova E. S., Kemenova V. A., Van den Mooter G. Interpolyelectrolyte complexes of Eudragit® EPO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Development and Industrial Pharmacy. 2009;35:1439-1451. Doi: 10.3109/03639040902988574.Sepulveda-Rivas S., Fritz H. F., Valenzuela C., Santiviago C. A., Morales J. O. Development of Novel EE/Alginate Polyelectrolyte Complex Nanoparticles for Lysozyme Delivery: Physicochemical Properties and In Vitro Safety. Pharmaceutics. 2019;11:103. Doi: 10.3390/pharmaceutics11030103.Sepulveda-Rivas S., Fritz H. F., Valenzuela C., Santiviago C. A., Morales J. O. Development of Novel EE/Alginate Polyelectrolyte Complex Nanoparticles for Lysozyme Delivery: Physicochemical Properties and In Vitro Safety. Pharmaceutics. 2019;11:103. Doi: 10.3390/pharmaceutics11030103.Wulff R., Leopold C. S. Coatings from blends of Eudragit® RL and L55: A novel approach in pH-controlled drug release. International Journal of Pharmaceutics. 2014;476:78-87. Doi: 10.1016/j.ijpharm.2014.09.023.Wulff R., Leopold C. S. Coatings from blends of Eudragit® RL and L55: A novel approach in pH-controlled drug release. International Journal of Pharmaceutics. 2014;476:78-87. Doi: 10.1016/j.ijpharm.2014.09.023.Khuathan N., Pongjanyakul T. Modification of quanternary polymethacrylate film using sodium alginate: Film characterization and drug permeability. International Journal of Pharmaceutics. 2014;460:63-72. Doi: 10.1016/j.ijpharm.2013.10.050.Khuathan N., Pongjanyakul T. Modification of quanternary polymethacrylate film using sodium alginate: Film characterization and drug permeability. International Journal of Pharmaceutics. 2014;460:63-72. Doi: 10.1016/j.ijpharm.2013.10.050.Semde R., Amighi K., Pierre D., Devleeschouwer M.J., Moёs A. J. Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery. International Journal of Pharmaceutics. 1998;174:233-241 . Doi: 10.1016/S0378-5173(98)00269-5.Semde R., Amighi K., Pierre D., Devleeschouwer M.J., Moёs A. J. Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery. International Journal of Pharmaceutics. 1998;174:233-241. Doi: 10.1016/S0378-5173(98)00269-5.Lefnaouri S., Moulai-Mostefa N. Polyelectrolyte complex based on carboxymethyl-kappa-carrageenan and Eudragit RL 30D as prospective carriers for sustained drug delivery. Chemical Engineering Research and Design. 2015;97:165-174. Doi: 10.1016/j.cherd.2014.12.006.Lefnaouri S., Moulai-Mostefa N. Polyelectrolyte complex based on carboxymethyl-kappa-carrageenan and Eudragit RL 30D as prospective carriers for sustained drug delivery. Chemical Engineering Research and Design. 2015;97:165-174. Doi: 10.1016/j.cherd.2014.12.006.Moustafine R. I., Margulis E. B., Sibgatullina L. F., Kemenova V. A., Van den Mooter G. Comparative evaluation of interpolyelectrolyte complexes of Chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2008;70:215-225. Doi: 10.1016/j.ejpb.2008.04.008.Moustafine R. I., Margulis E. B., Sibgatullina L. F., Kemenova V. A., Van den Mooter G. Comparative evaluation of interpolyelectrolyte complexes of Chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2008;70:215-225. Doi: 10.1016/j.ejpb.2008.04.008.Мустафин Р. И., Семина И. И., Гарипова В. Р., Буховец А. В., Ситенков А. В., Салахова А. Р., Gennari C. G. M., Cilurzo F. Сравнительное исследование поликомплексов на основе Carbopol® и противоположно заряженных полиэлектролитов как новых систем пероральной доставки. Химико-фармацевтический журнал. 2015;49(1):3-8. Doi: 10.30906/0023-1134-2015-49-1-3-8.Mustafin R. I., Semina I. I., Garipova V. A., Bukhovets A. V., Sitenkov Y. A., Salakhova A. R., Gennari C. G. M., Cilurzo F. Comparative study of polycomplexes based on Carbopol® and oppositely charged polyelectrolytes as a new oral drug delivery system. Himiko-farmacevticheskij zhurnal = Pharmaceutical Chemistry Journal. 2015;49(1):1-6. Doi: 0091-150X/15/4901-0001. (In Russ.).Garipova V. R., Gennari C. G. M., Selmin F., Cilurzo F., Moustafine R. I. Mucoadhesive Interpolyelectrolyte Complexes for the Buccal Delivery of Clobetasol. Polymers. 2018; 10(2): 85. Doi: 10.3390/polym10010085.Garipova V. R., Gennari C. G. M., Selmin F., Cilurzo F., Moustafine R. I. Mucoadhesive Interpolyelectrolyte Complexes for the Buccal Delivery of Clobetasol. Polymers. 2018;10(2):85. Doi: 10.3390/polym10010085.Мустафин Р. И., Будников В. В., Абдуллина С. Г., Насибуллин Ш. Ф., Салеев Р. А. Поликомплексный носитель для трансбуккальной мукоадгезивной доставки метронидазола. Разработка и регистрация лекарственных средств. 2020;2(9):81-88. Doi: 10.33380/2305-2066-2020-9-1-13-17.Moustafine R. I., Budnikov V. V., Abdullina S. G., Nasibullin S. F., Saleev R. A. Polycomplex carrier for buccal mucoadhesion delivery of metronidazole. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2020;2(9):81-88. Doi: 10.33380/23052066-2020-9-1-13-17. (In Russ.).Мустафин Р. И., Протасова А. А., Буховец А. В., Семина И. И. Исследование интерполимерных сочетаний на основе (мет)акрилатов в качестве перспективных носителей в поликомплексных системах для гастроретентивной доставки. Фармация. 2014;5:3-5.Mustafin R. I., Protasova A. A., Bukhovets A. V., Semina I. I. Investigation of interpolymers based on (meth)acrylates as promising carriers in multiplex gastroretentive drug delivery systems. Farmaciya = Farmatsiya. 2014;5:3-5. (In Russ.).Мустафин Р. И., Буховец А. В., Протасова А. А., Шайхрамова Р. Н., Ситенков А. Ю., Семина И. И. Сравнительное исследование поликомплексных систем для гастроретентивной доставки метформина. Разработка и регистрация лекарственных средств. 2015;1(10):48-50.Mustafin R. I., Bukhovets A. V., Protasova A. A., Shaykhramova R. N., Sitenkov A. Y., Semina I. I. Comparative investigation of polycomplex systems for gastroretentive metformin delivery. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2015;1(10):48-50. (In Russ.).Гордеева Д. С., Ситенкова (Буховец) А. В., Мустафин Р. И. Интерпо-лиэлектролитные комплексы на основе сополимеров Eudragit® как носители для систем биоадгезивной гастроретентивной доставки метронидазола. Разработка и регистрация лекарственных средств. 2020;2(9):72-76. Doi: 10.33380/2305-2066-2020-92-72-76.Gordeeva D. S., Sitenkova (Bukhovets) A. V., Moustafine R. I. Interpolyelectrolyte complexes based on Eudragit® copolymers as carriers for bioadhesive gastroretentive metronidazole delivery system. Razrabotka i registratsiya lekarstvennykh sredstv = Drug development & registration. 2020;2(9):72-76. Doi: 10.33380/23052066-2020-9-2-72-76. (In Russ.).Bukhovets A. V., Fotaki N., Khutoryanskiy V. V., Moustafine, R. I. Interpolymer complexes of Eudragit® copolymers as novel carriers for colon-specific drug delivery. Polymers. 2020;12:1459. Doi: 10.3390/polym12071459.Bukhovets A. V., Fotaki N., Khutoryanskiy V. V., Moustafine, R. I. Interpolymer complexes of Eudragit® copolymers as novel carriers for colon-specific drug delivery. Polymers. 2020;12:1459. Doi: 10.3390/polym12071459.Мустафин Р. И., Ситенкова A. В., Ситенков A. Ю., Семина И. И. Интерполимерный носитель для пероральных систем контролируемой доставки активных фармацевтических ингредиентов. Патент РФ № 2725879 (заявл. 26.07.2018; опубл. 7.07.2020, бюл. № 19).Mustafin R. I., Sitenkova A. V., Sitenkov A. Y., Semina I. I., Interpolymer carrier for oral systems of controlled delivery of active pharmaceutical ingredients. Russian Patent (RU) № 2725879 (filed. 26.07.2018; publ. 7.07.2020, bul. No. 19). (In Russ.).Amidon G. L., Lennerns H., Shah V. P., Crison J. R. Theoretical Basis for a Biopharmaceutics Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability. Pharmaceutical Research. 1995;12(3):413-420. Doi: 10.1023/a:1016212804288.Amidon G. L., Lennerns H., Shah V. P., Crison J. R. Theoretical Basis for a Biopharmaceutics Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability. Pharmaceutical Research. 1995;12(3):413-420. Doi: 10.1023/a:1016212804288.Lorenzo-Lamoza M. L., Remunan-Lopez C., Vila-Jato J. L., Alonso M. J. Design of microencapsulated chitosan microspheres for colonic drug delivery. Journal of Controlled Release. 1998;52:109-118. Doi: 10.1016/S0168-3659(97)00203-4.Lorenzo-Lamoza M. L., Remunan-Lopez C., Vila-Jato J. L., Alonso M. J. Design of microencapsulated chitosan microspheres for colonic drug delivery. Journal of Controlled Release. 1998;52:109-118. Doi: 10.1016/S0168-3659(97)00203-4.Korsmeyer R. W., Gurny R., Docler E., Buri P., Peppas N. A. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics. 1983;15:25-35. Doi: 10.1016/0378-5173(83)90064-9.Korsmeyer R. W., Gurny R., Docler E., Buri P., Peppas N. A. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics. 1983;15:25-35. Doi: 10.1016/0378-5173(83)90064-9.

The authors declare that there are no conflicts of interest present.